Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.1%

2 terminated/withdrawn out of 28 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
15(93.8%)
Phase 2
1(6.3%)
16Total
N/A(15)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT04008615Completed

Comparison of the Cardiopulmonary and Gaz-exchange Response Between the Six-minute Stepper Test and the Incremental Cardiopulmonary Exercise Testing in Patients With Chronicle Obstructive Pulmonary Disease

Role: lead

NCT06956742Not ApplicableRecruiting

Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Disease

Role: lead

NCT05314686Completed

Telerehabilitation - Technical Validity and Clinical Feasibility

Role: lead

NCT07025382Not ApplicableRecruiting

Telerehabilitation Versus Centre-based Pulmonary Rehabilitaztion for Patients With Chronic Obstructive Pulmonary Disease

Role: lead

NCT06866717Not ApplicableRecruiting

Hybrid Prehabilitation Before Thoracic Surgery

Role: lead

NCT04380558Completed

Prevalence and Consequences of Urinary Incontinence in People with Chronic Pulmonary Diseases Referred for Pulmonary Rehabilitation

Role: lead

NCT06703359Recruiting

Predictive Properties of the 6-Minute Stepper Test for Mortality in COPD

Role: lead

NCT06079151Not ApplicableRecruiting

Hemodynamic Effect of Nasal High-flow in Patients Suspected or Followed for a Precapillary Pulmonary Hypertension

Role: lead

NCT02842463Completed

6-minute Stepper Test and Pulmonary Rehabilitation in Patients With Chronicle Obstructive Pulmonary Disease

Role: lead

NCT06182956Not ApplicableNot Yet Recruiting

NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases

Role: lead

NCT03882372Not ApplicableTerminated

Nasal High Flow to Maintain the Benefits of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients

Role: lead

NCT04189991Not ApplicableSuspended

Oxygen Titration Protocol for Exertion of COPD Patients by an Automated Adjustment Device

Role: lead

NCT04004689Unknown

6-minute Stepper Test and Pulmonary Rehabilitation in Patients With Severe to Very Severe Chronicle Obstructive Pulmonary Disease

Role: lead

NCT05372926Not ApplicableUnknown

Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases

Role: lead

NCT04014868Not ApplicableCompleted

During-exercise Physiological Effects of Nasal High-flow in Patients With Chronic Obstructive Pulmonary Disease

Role: lead

NCT04041297Completed

Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During Prehabilitation

Role: lead

NCT03936764Not ApplicableCompleted

Effect of Two Different Preoperative Training Densities in Patients With Non-small-cell Lung Cancer Before Lung Resection Surgery

Role: lead

NCT04301245Completed

Profile of COPD Patients Refusing Educational Program in Pulmonary Rehabilitation and Impact on the Benefits

Role: lead

NCT03244137Completed

Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease

Role: lead

NCT02805439Phase 2Completed

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Role: collaborator